The Finnish Pharmaceutical Insurance Pool has said it expects the first claims in relation to those who developed narcolepsy after receiving the Pandemrix vaccine to be settled in October-November.
Compensation will be paid for both temporary and permanent effects experienced by people who got the vaccine.
So far, the Pharmaceutical Insurance Pool has received more than 70 compensation claims. Narcolepsy sufferers can lodge claims for another three years.
Hilary Dowdall, one of the founding members of SOUND (Sufferers of Unique Narcolepsy Disorder), said Irish parents would welcome a similar type scheme.
“That sort of set-up would be fantastic. At the moment, our focus is on the children’s current needs, particularly education, and a lot of parents have had to fight individually for their needs to be addressed. But we don’t know what the future holds, for example in turns of the capability of someone with narcolepsy holding down a job.
“So it would be good to know that there would be some kind of provision for their future,” Ms Dowdall said.
She said a number of parents of the approximately 30 people affected by narcolepsy post-Pandemrix were taking legal advice.
Her own daughter Chloe received the vaccine aged 10 and quickly developed narcolepsy with cataplexy.
The latter is a sudden loss of muscle tone ranging from slackness of facial muscles to total collapse. Initially, she feared her daughter may have a brain tumour but after seven months of to-ing and fro-ing with doctors, she was diagnosed by a consultant in Temple St Children’s Hospital, who had been made aware by an overseas colleague of the possible serious side-effect of Pandemrix.
Last Saturday, parents of children ranging in age from six to 18 attended the official launch in Dublin of SOUND, a support and information group for the parents.
Group chairwoman Mary Fitzpatrick, has received confirmation from Health Minister Dr James Reilly that he will meet with them shortly to discuss their concerns.
HSE clinics and GPs administered over 900,000 doses of Pandemrix during the H1N1 pandemic in 2009/2010.
Last Friday, the HSE confirmed it was aware of approximately 30 new cases of potential narcolepsy in children and adolescents.
The HSE said it was making contact with affected families and is seeking advice from Scandinavian countries on how to help.